Cassava and former executives were charged Thursday by the SEC with making misleading claims in 2020 about trials for the ...

Pfizer’s decision Wednesday to pull its sickle cell pill off the market because of safety concerns shocked advocates and ...

Cobenfy was approved to reduce the psychotic symptoms associated with schizophrenia. It is a new type of medicine that works ...

The company said benefits no longer outweighed the risks, with data suggesting the drug might increase the risk of pain ...

Sen. Maggie Hassan of New Hampshire is the lead Democrat in the Senate pushing to equalize payments between hospitals and ...

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

Particle Health's antitrust lawsuit is a direct threat to Epic Systems' dominance in the multi-billion dollar market for ...

Medicare’s controversial decision to condition coverage for even fully approved Alzheimer’s drugs is here to stay, per a top ...

Rise and shine, everyone, another busy day is on the way. However, this is shaping up as a lovely day as well, despite ...

After years of pressure, the FDA said it is strengthening its review of many chemical additives used to enhance color, ...

AbbVie reported Thursday that its experimental Parkinson’s drug that it got from Cerevel Therapeutics helped alleviate ...

Biden administration officials have abandoned their own proposal to require drug companies to disclose the prices and ...